Integrative pan-cancer analysis and experiment validation identified GLS as a biomarker in tumor progression, prognosis, immune microenvironment, and immunotherapy
Dongming Li(Dalian University), Xueyuan Cao(St. Jude Children's Research Hospital), Donghui Cao(Jilin University), Yanhua Wu(Jilin University), Xinyi Yu(Jilin University), Zhifang Jia(Jilin University), Yangyu Zhang(Fuzhou University)
Cited by 14
Related Papers
Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial
|The Lancet Oncology|2010|586
The genomic landscape of core-binding factor acute myeloid leukemias
|Nature Genetics|2016|277
Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia
|Nature Genetics|2011|276
Association of Cerebral Deficits With Clinical Symptoms in Antipsychotic-Naive First-Episode Schizophrenia: An Optimized Voxel-Based Morphometry and Resting State Functional Connectivity Study
|American Journal of Psychiatry|2008|257
Fabrication and Electrochemical Treatment Application of A Novel Lead Dioxide Anode with Superhydrophobic Surfaces, High Oxygen Evolution Potential, and Oxidation Capability
|Environmental Science & Technology|2010|237